GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Xvivo Perfusion AB (OSTO:XVIVO) » Definitions » Sale Of Investment

Xvivo Perfusion AB (OSTO:XVIVO) Sale Of Investment : kr0.0 Mil (TTM As of Mar. 2024)


View and export this data going back to 2012. Start your Free Trial

What is Xvivo Perfusion AB Sale Of Investment?

Xvivo Perfusion AB's sale of investment for the three months ended in Mar. 2024 was kr0.0 Mil. It means Xvivo Perfusion AB gained kr0.0 Mil from selling investments. Xvivo Perfusion AB's sale of investment for the trailing twelve months (TTM) ended in Mar. 2024 was kr0.0 Mil.

Compared with last quarter (kr0.0 Mil in Dec. 2023 ), Xvivo Perfusion AB gained the same money from selling investments in Mar. 2024 (kr0.0 Mil).

Xvivo Perfusion AB Sale Of Investment Historical Data

The historical data trend for Xvivo Perfusion AB's Sale Of Investment can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Xvivo Perfusion AB Sale Of Investment Chart

Xvivo Perfusion AB Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Sale Of Investment
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - 0.77 -

Xvivo Perfusion AB Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Sale Of Investment Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Xvivo Perfusion AB Sale Of Investment Calculation

Sale of Investments represents cash inflow on the sale of investments in securities.

Sale Of Investment for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was kr0.0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Xvivo Perfusion AB Sale Of Investment Related Terms

Thank you for viewing the detailed overview of Xvivo Perfusion AB's Sale Of Investment provided by GuruFocus.com. Please click on the following links to see related term pages.

Xvivo Perfusion AB (OSTO:XVIVO) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Xvivo Perfusion AB (OSTO:XVIVO) » Definitions » Sale Of Investment
Comparable Companies
OSTO:MCAP OSTO:CEVI OSTO:BACTI B OSTO:BICO OSTO:SEDANA OSTO:CRAD B OSTO:BRAIN OSTO:MNTC OSTO:SEZI OSTO:INTEG B ABT SYK MDT BSX SZSE:300760 EW DXCM ZBH STE XAMS:PHIA
Traded in Other Exchanges
XVIPF:USA 3XV:Germany
Address
Massans gata 10, P.O. Box 53015, Gothenburg, SWE, SE-400 14
Website
https://www.xvivoperfusion.com
Xvivo Perfusion AB is a medical technology company dedicated to extending the life of all major organs so transplant teams around the world can save more lives. Its solutions allow clinicians and researchers to push the boundaries of transplantation medicine. It operates in three segments namely, Thoracic: Sales of lung and heart transplant products, Abdominal: Sales of liver and kidney transplant products. Services: Revenue from sales of services in organ recovery (carried out by subsidiary STAR Teams Inc.). The majority of revenue is derived from the Thoracic segment. Geographically, the majority is from the United States.

Xvivo Perfusion AB (OSTO:XVIVO) Headlines

No Headlines